US Patent:
20100210700, Aug 19, 2010
Inventors:
Malaz Abutarif - North Brunswick NJ, US
Paul Statkevich - Raritan NJ, US
International Classification:
A61K 31/4188
A61P 35/00
Abstract:
This invention relates to methods and drug products for treating proliferative disorders using intravenous formulations comprising temozolomide over a specific infusion time. These methods and drug products are particularly well-suited for patients who cannot swallow oral formulations. These methods and drug products also afford an added convenience to patients who are already receiving other therapeutic treatments.